Kuros Biosciences AG/ CH0325814116 /
| 2024-11-15 5:18:12 PM | Chg. -6.45 | Volume | Bid5:20:00 PM | Ask5:20:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 25.00CHF | -20.51% | 28,769 Turnover: 788,496.70 |
-Bid Size: - | -Ask Size: - | 912.21 mill.CHF | - | - |
Assets
| 2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 0.0000 | 0.0000 | .6000 | .6000 | .5000 | ||||||
| Intangible Assets | 0.0000 | 6.6000 | 33.2000 | 31.1000 | 27.9000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 0.0000 | 30.4000 | 68.4000 | 66 | 64.6000 | ||||||
| Inventories | 0.0000 | 0.0000 | .2000 | .4000 | .5000 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 15.9000 | 12.4000 | 16.7000 | 18.3000 | 20.8000 | ||||||
| Current Assets | 16.2000 | 13.4000 | 17.7000 | 19.8000 | 23.3000 | ||||||
| Total Assets | 16.2000 | 43.8000 | 86.1000 | 85.8000 | 87.9000 | ||||||
Liabilities
| 2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1 | 1.3000 | 1.3000 | 1.6000 | 1.1000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 3.7000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | .4000 | 2 | 1.7000 | 2.1000 | 2.3000 | ||||||
| Liabilities | 5.7000 | 5.4000 | 12.9000 | 9.3000 | 10 | ||||||
| Share Capital | 1.3000 | 5.1000 | 8.2000 | 15.1000 | 22.5000 | ||||||
| Total Equity | 10.4000 | 38.3000 | 73.1000 | 76.5000 | 77.9000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 16.2000 | 43.8000 | 86.1000 | 85.8000 | 87.9000 | ||||||
Income Statement
| 2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | .2000 | 1.1000 | .5000 | .7000 | 2.6000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -4.2000 | -21.3000 | -16.2000 | -13.7000 | -11.4000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -5.8000 | -20.3000 | -16.6000 | -13.8000 | -11.8000 | ||||||
| Income Taxes | 0.0000 | .6000 | .1000 | 2.1000 | .5000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -5.8000 | -19.7000 | -16.5000 | -11.7000 | -11.3000 | ||||||
Per Share
Cash Flow
| 2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -2.6000 | -8.9000 | -10.7000 | -12.8000 | -10.8000 | ||||||
| Cash Flow from Investing Activities | 0.0000 | 1.8000 | -.9000 | -.7000 | -.1000 | ||||||
| Cash Flow from Financing | 17 | 3.5000 | 16 | 15 | 13.1000 | ||||||
| Decrease / Increase in Cash | 14.4000 | -3.6000 | 4.4000 | 1.5000 | 2.2000 | ||||||
| Employees | 4 | 16 | 28 | 9 | 6 | ||||||
